Clinical Trial Starts In Autoimmune/Inflammatory Diseases Shift From Rheumatology To Asthma And COPD Disorders.
A comprehensive review of clinical trial starts in the autoimmune/inflammation therapeutic area found that over a one year period that focus has shifted from rheumatology to respiratory diseases, COPD and Asthma saw the highest levels of activity, and inhaled combinations therapies dominate respiratory developments. Medical News Today. 05/10/11. (Also see: Clinical Trials)
These items were posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Clinical Trial Starts In Autoimmune/Inflammatory Diseases Shift From Rheumatology To Asthma And COPD Disorders
No replies to this topic